Seeking Young Scientists for Research in Space
Sounds of Science Podcasts
Tackling the Inevitability of Resistance One Genome at a Time
Long Noncoding RNAs: Clarity or Confusion?
Because They Are Such Elusive Prey, lncRNAs Have Yet to Emerge as Therapeutic Targets
Markets Expand for Single-Use Bioreactors
Biobags Offer Advantages Over Fixed-Tank Systems
Biotechnology has been a global industry for years, yet patent laws and agencies are still mostly national in scope. Not surprisingly, smaller biotech businesses, often cash-strapped and limited to the knowledge of their management and investors, find it a hurdle if they intend to grow into successful global enterprises. Industry advocates are looking to help those smaller companies protect their patents for treatments, technologies, and other intellectual property; details here. How to help is under study by the US Patent and Trademark Office (USPTO), which is compiling recommendations for helping smaller businesses in and outside the life sciences gain international patent protection. Among questions the USPTO report is intended to answer is what role, if any, should the federal government play. What do think?